HistoSonics, Inc.

HistoSonics, Inc.

HistoSonics, Inc.

Date Founded



3626 West Liberty Road,Ann Arbor, MI 48103-9049

Type of Company


Employees (Worldwide)

11 - 50


Medical Products & Equipment
Hospitals & Patient Services
Holding Companies

Company Description

HistoSonics, Inc. develops medical devices. The company was founded by Christine Gibbons, Jim Bertolina, Zhen Xu, William Robert, Hall Timothy, J. Brian Fowlkes, Thomas W. Davison, and Charles Cain in November 2009 and is headquartered in Ann arbor, MI.

Executives & Employees

President, Chief Executive Officer, Board Member

Chief Financial Officer

Vice President of Global Business Development

Vice President of Clinical, Regulatory & Quality

Vice President of Regulatory & Clinical Affairs

Vice President of Operations

Vice President of Marketing

Vice President of Research & Development

Senior Medical Advisor

Inventor, Co-Founder, Chairman of Scientific Advisory Board

Board of Directors

Managing Director at Venture Investors LLC

Executive Chairman at IMRIS Inc.

Former Vice President & Controller for Europe, Middle East & Africa at Medtronic, Inc.

Principal, Venture Investments at Johnson & Johnson Innovation JJDC, Inc.

Managing Director at Lumira Capital Investment Management, Inc.

Co-Founder & Board of Directors at NeuWave Medical, Inc.

President, Chief Executive Officer, Board Member at HistoSonics, Inc.

Vice President of Research & Development at HistoSonics, Inc.

Paths to HistoSonics, Inc.
Potential Connections via
Relationship Science
HistoSonics, Inc.
Recent Transactions
Details Hidden

HistoSonics, Inc. raised money in a private placement transaction

Details Hidden

HistoSonics, Inc. raised money in a private placement transaction

Details Hidden

HistoSonics, Inc. raised money in a private placement transaction

Details Hidden

Founder at Auris Surgical Robotics, Inc.

Details Hidden

Venture Investors invests in the healthcare, technology and clean technology sectors. They seek companies with proprietary products or services that offer distinct competitive advantages that are sustainable over time. The competitive advantage should be quantifiable and with meaningful barriers to competitive entry. The firm invests in companies located in the Midwestern US. Investments range from $50,000 to $8 million over the life of the investment.

Details Hidden

LUMIRA primarily focuses on later stage biopharmaceutical and medical device companies located in US and Canada. The firm partners with management teams and also invests in health IT and consumer health sectors.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by HistoSonics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of HistoSonics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and HistoSonics, Inc..